Literature DB >> 14978023

IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms.

Olivier Wurtz1, Marc Bajénoff, Sylvie Guerder.   

Abstract

The mechanisms by which Th1 and Th2 cells inter-regulate in vivo are still poorly understood. In this study we examined the plasticity of Th1 cell differentiation and how Th2 cells may down-regulate these responses. We show here that IL-4 affects Th1 cell responses by two developmentally regulated mechanisms. During the commitment phase of naive CD4+ T cells, IL-4 inhibits Th1 cell differentiation and induces a reversion of developing Th1 cells to the Th2 lineage. In contrast, for effector Th1 cells IL-4 does not affect the developmental process, but only the transcription of the IFN-gamma gene. We further show that the difference in IL-4 responsiveness correlates with a loss, in effector Th1 cells, of IL-4-dependent up-regulation of GATA-3 expression despite normal activation of STAT6. Transient inhibition of IFN-gamma production by differentiated effector cells may explain why Th1 and Th2 responses can co-exist in vivo although Th2 effector cells dominate functionally, as observed in some infectious or autoimmune mice models.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978023     DOI: 10.1093/intimm/dxh050

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  27 in total

1.  Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Khoa D Nguyen; Leonard A Herzenberg; Alan M Krensky; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2007-10-24       Impact factor: 10.793

Review 2.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

3.  TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens.

Authors:  Carolyn R Sturge; Alicia Benson; Megan Raetz; Cara L Wilhelm; Julie Mirpuri; Ellen S Vitetta; Felix Yarovinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 4.  Regulation of pro- and anti-atherogenic cytokines.

Authors:  Mitali Ray; Michael V Autieri
Journal:  Cytokine       Date:  2017-12-06       Impact factor: 3.861

Review 5.  T cells in atherosclerosis.

Authors:  Kevin Tse; Harley Tse; John Sidney; Alex Sette; Klaus Ley
Journal:  Int Immunol       Date:  2013-11       Impact factor: 4.823

6.  Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.

Authors:  Martin A Kriegel; Theresa Tretter; Norbert Blank; Martin Schiller; Christoph Gabler; Silke Winkler; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  Immunology       Date:  2006-06-06       Impact factor: 7.397

Review 7.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

8.  Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice.

Authors:  Daofeng Qu; Jianzhong Han; Aifang Du
Journal:  Parasitol Res       Date:  2013-04-17       Impact factor: 2.289

9.  A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.

Authors:  Sten-Erik Bergström; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

10.  IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population.

Authors:  Wenzhao Liu; Hongxia Dan; Zhi Wang; Lu Jiang; Yu Zhou; Man Zhao; Qianming Chen; Xin Zeng
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.